IL-6 Gene Expression as a Marker of Pathological State in Psoriasis and Psoriatic Arthritis

Bull Exp Biol Med. 2022 May;173(1):77-80. doi: 10.1007/s10517-022-05497-0. Epub 2022 May 27.

Abstract

The expression of the IL-6 gene in mononuclear blood cells of 45 patients with psoriatic arthritis and 31 patients with plaque psoriasis was studied for possible differential diagnosis of the pathologies. The expression level of IL-6 in psoriatic arthritis and psoriasis surpassed that in healthy controls by 192 and 147 times, respectively. Significant differences in the gene expression were revealed between the patients with psoriatic arthritis and mild psoriasis. The level of IL-6 in patients with severe psoriasis approached that in patients with psoriatic arthritis. High level of IL-6 gene expression can be a marker of possible joint damage in patients with psoriasis and a signal for revising the therapeutic approach in a particular patient.

Keywords: IL-6; RT-PCR; gene expression; psoriasis; psoriatic arthritis.

MeSH terms

  • Arthritis, Psoriatic* / diagnosis
  • Arthritis, Psoriatic* / genetics
  • Arthritis, Psoriatic* / metabolism
  • Biomarkers / metabolism
  • Gene Expression
  • Humans
  • Interleukin-6* / biosynthesis
  • Interleukin-6* / genetics
  • Psoriasis* / diagnosis
  • Psoriasis* / genetics
  • Psoriasis* / metabolism

Substances

  • Biomarkers
  • IL6 protein, human
  • Interleukin-6